Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.

MLA

Su, Yapeng, et al. “Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.” Cell, vol. 183, no. 6, Dec. 2020, p. 1479. EBSCOhost, https://doi.org/10.1016/j.cell.2020.10.037.

APA

Su, Y., Chen, D., Yuan, D., Lausted, C., Choi, J., Dai, C. L., Voillet, V., Duvvuri, V. R., Scherler, K., Troisch, P., Baloni, P., Qin, G., Smith, B., Kornilov, S. A., Rostomily, C., Xu, A., Li, J., Dong, S., Rothchild, A., … Heath, J. R. (2020). Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19. Cell, 183(6), 1479. https://doi.org/10.1016/j.cell.2020.10.037

Chicago

Su, Yapeng, Daniel Chen, Dan Yuan, Christopher Lausted, Jongchan Choi, Chengzhen L Dai, Valentin Voillet, et al. 2020. “Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19.” Cell 183 (6): 1479. doi:10.1016/j.cell.2020.10.037.